Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Danaher Corporation (NYSE:DHR) and AstraZeneca PLC (NASDAQ:AZN) have announced a major partnership to accelerate the ...

Shares of Danaher Corp. slipped 5.54% to $186.81 Wednesday, on what proved to be an all-around poor trading session for the ...

Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An ...

DHR and AstraZeneca team up to develop AI-powered diagnostics, aiming to boost precision medicine by improving patient ...

The focus will initially be on creating computational and digital pathology products, as well as AI-assisted algorithms.

Danaher Corp. closed 34.49% below its 52-week high of $281.70, which the company achieved on August 1st.

Sept 14 (Reuters) - Danaher Corp (DHR.N), opens new tab said on Wednesday it would separate its environmental & applied solutions (EAS) segment to pivot growth towards the medical technology firm ...

Danaher Corporation, a key player in Life Sciences, Biotechnology, and Diagnostics, has shown mixed financial performance with recent declines in revenue and net earnings. Despite recent struggles ...

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments ...

Danaher Corporation incorporates science and technology and has a market cap of $150B. The company has mixed financials, with its gross profit margin being its strongest and most consistent.